(Q35763133)

10 August 2017

title

Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients (English)

1 reference

10 August 2017

1 reference

10

Jean-Charles Piette

1 reference

10 August 2017

5

Nathalie Cassoux

1 reference

10 August 2017

Bahram Bodaghi

1

1 reference

10 August 2017

Gael Gendron

2

1 reference

10 August 2017

Bertrand Wechsler

3

1 reference

10 August 2017

Céline Terrada

4

1 reference

10 August 2017

Du Le Thi Huong

6

1 reference

10 August 2017

Claire Lemaitre

7

1 reference

10 August 2017

Christine Fradeau

8

1 reference

10 August 2017

Phuc LeHoang

9

1 reference

10 August 2017

language of work or name

English

0 references

publication date

18 October 2006

1 reference

British Journal of Ophthalmology

10 August 2017

published in

1 reference

10 August 2017

volume

91

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

335-339

1 reference

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Interferon alpha-2a treatment for serpiginous choroiditis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Immunosuppression for posterior uveitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Infliximab in refractory uveitis due to Behçet's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

The use of interferon alpha in Behçet disease: review of the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Bone marrow hypoplasia and fibrosis following interferon treatment.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Clinical toxicity of interferons in cancer patients: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Efficacy of interferon-alpha for the treatment of Kaposi's sarcoma herpesvirus-associated uveitis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Uveitis in Behçet disease: an analysis of 880 patients.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Interferon alfa-2a in the treatment of ocular Adamantiades-Behçet's disease

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Infliximab in the treatment of refractory posterior uveitis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Familial recurrent bilateral panuveitis: efficiency of alpha interferon

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

[Interferons and Behçet's disease].

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Visual loss during interferon-alpha therapy in hepatitis C virus infection

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1857681

Standardization of vitreal inflammatory activity in intermediate and posterior uveitis

25 September 2018

1 reference

12 December 2020

Results of interferon-alfa therapy in patients with Behçet uveitis

1 reference

12 December 2020

International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease

1 reference

12 December 2020

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

1 reference

12 December 2020

Interferon-alpha 2b for refractory ocular Behçet's disease

1 reference

12 December 2020

Anterior ischemic optic neuropathy secondary to interferon alfa

1 reference

12 December 2020

Interferon alpha for ocular Behçet's disease

1 reference

12 December 2020

Natural interferon therapy: optic nerve ischemic damage?

1 reference

12 December 2020

Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center

1 reference

12 December 2020

Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease

1 reference

12 December 2020

The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease

1 reference

12 December 2020

Influence of human recombinant interferon- 2a (rhIFN- 2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease

1 reference

12 December 2020

Infliximab for chronic cystoid macular edema associated with uveitis

1 reference

12 December 2020

Treatment of Adamantiades-Behçet disease with systemic interferon alfa

1 reference

12 December 2020

Interferon-alpha treatment of Behçet's disease

1 reference

12 December 2020

Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma

1 reference

12 December 2020

Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.2006.101550

1 reference

release_rb2ujb3b6bdi7ipuhwjo3oic5u

10 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rb2ujb3b6bdi7ipuhwjo3oic5u

24 November 2022

mapped directly with Wikidata item

PMC publication ID

1857681

1 reference

10 August 2017

1 reference